Best Practices for APL Testing: Dr. Michelle Petri
Dr. Jack Cush interviews Dr. Petri about the comparative value of lupus anticoagulant vs. other antiphospholipid antibody tests and their role in CVA or MI - looking at abstracts #1261, #1262 and #1266 presented at the 2020 ACR Annual Meeting.
Hesitancy around Steroids and Vaccines: Dr. Kevin Winthrop
OHSU's Dr. Kevin Winthrop discusses two issues -- steroids and vaccines -- by looking at abstracts #1014, #0632, #0634 and #1135 at ACR 2020.
Roundtable on Gout: What's Hot at ACR 2020 with Gout Faculty
Drs. Michael Pillinger, Naomi Schlesinger and Robert Keenan discuss the hot topics in Gout in a panel discussion at ACR 2020.
Tight Control Tune: Third Verse, Same as the First? TICOSPA. Dr. Jeff Curtis
Dr. Jeff Curtis reviews abstract #1444 (results of the TICOSPA trial) at the 2020 ACR annual meeting.
Missing the Mark: AxSpa Treat to Target (TICOSPA Trial): Dr. Lianne Gensler
Dr. Lianne Gensler discusses abstract #1444 - the results of the TICOSPA trial - and its importance despite a negative outcome at the 2020 ACR annual meeting.
A New Pathway in Psoriatic Arthritis: Dr. Eric Ruderman
Dr. Ruderman discusses a new pathway - the use of deucravacitinib - for the treatment of psoriatic arthritis (abstracts L03) at the ACR 2020 annual meeting.
How bad is COVID19 for rheumatic disease patients? Dr. Jeff Curtis
Dr. Jeffrey Curtis reviews abstract L01 presented Monday at the 2020 ACR annual meeting.
The Lungs: The Alpha and Omega of RA with Dr. Jonathan Kay
Dr. Kay reviews abstract #1445 presented at the 2020 ACR annual meeting.
Measuring Disease Activity in Psoriatic Arthritis: Dr. Eric Ruderman
Dr. Ruderman looks at abstracts #0884, #0323 and #0909, which focus on disease activity measurement in psoriatic arthritis.
Potpourri of Pathotypes of Predictors with RA Faculty
Dr. Jonathan Kay again leads an international panel of rheumatologists to elicit their opinions on key abstracts at ACR 2020. Panelists: Dr. David Liew, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway, Dr. Sheila Reyes and Dr. Jeffrey Sparks.
Improving Response to Pegloticase: Dr. Nicola Dalbeth
Auckland-based rheumatologist Dr. Nicola Dalbeth discusses improving responses to the use of Pegloticase, including abstracts #0677 and #0952.
Nomenclature, Uveitis and Other Spondyloarthritis Features: Dr. Lianne Gensler
Dr. Gensler reviews her top selections for ACR 2020 today, including abstract #0881 and #0876. She also highlighted the study group on spondyloarthritis, which focused on nomenclature.
COVID and Rheumatic Disease Patients: Dr. Kevin Winthrop
Portland-based Dr. Kevin Winthrop from OHSU discusses Saturday ACR 2020 posters #0623 and #0629 related to COVID-19 and RA patients.
GCAN Report: Gout, Urate and the repositioning of innate immunity: Dr. Michael Pillinger
NYU's Dr. Michael Pillinger promises deeper looks at ACR 2020 activity regarding gout, but starts out reporting data from GCAN.
Shifting Treatment Paradigms in Psoriatic Arthritis: Dr. Eric Ruderman
Chicago-based Dr. Eric Ruderman discussed the shifting treatment paradigms in psoriatic arthritis by reviewing abstracts #0504 and #2026 at ACR 2020.
Poster Hall